FDA puts two Chinese API makers on import alert after failed inspectionsnews2025-02-11T18:24:55+00:00February 11th, 2025|Endpoints News|
Trump’s tariff impact likely ‘minimal’ for brand-name drugmakers news2025-02-10T18:22:08+00:00February 10th, 2025|Endpoints News|
Post-Hoc: China tensions both help and hurt Illuminanews2025-02-07T20:07:11+00:00February 7th, 2025|Endpoints News|
AstraZeneca offers some detail on China probe, reaffirms commitment to that marketnews2025-02-06T12:36:59+00:00February 6th, 2025|Endpoints News|
Merck CEO says he’s confident in growth despite Gardasil ‘headwind’news2025-02-04T19:41:34+00:00February 4th, 2025|Endpoints News|
Illumina added to China’s blacklist following Biosecure Act, tariffsnews2025-02-04T17:00:18+00:00February 4th, 2025|Endpoints News|
Merck pauses Gardasil shipments to Chinanews2025-02-04T11:30:48+00:00February 4th, 2025|Endpoints News|
Biogen’s research chief talks China, neuropsychiatry and pipeline plannews2025-02-03T18:45:35+00:00February 3rd, 2025|Endpoints News|
Gazans Trek Home, and Trump’s Tariff Spat With Colombianews2025-01-27T11:00:35+00:00January 27th, 2025|The New York Times|
In China, Government Data on Drugs Blocked From Public After Backlashnews2025-01-27T10:51:18+00:00January 27th, 2025|The New York Times|